Large-scale testing (Phase 3)Ended earlyNCT00050375What this trial is testingClinical Trial for Ovarian Cancer (OvaRex®)Who this might be right forOvarian Cancer Unither Pharmaceuticals 354
Testing effectiveness (Phase 2)Study completedNCT00004060What this trial is testingChemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Daiichi Sankyo
Not applicableNot Yet RecruitingNCT06393543What this trial is testingInternational Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal CarcinomatosisWho this might be right forBRCA MutationSerous Tubal Intraepithelial CarcinomaOvarian Carcinoma+1 more Radboud University Medical Center 600
Large-scale testing (Phase 3)Study completedNCT03598270What this trial is testingPlatinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian CancerWho this might be right forRecurrent Ovarian Carcinoma Grupo Español de Investigación en Cáncer de Ovario 417
Early research (Phase 1)Study completedNCT00437502What this trial is testingA Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal CancerWho this might be right forEpithelial Ovarian, Tubal or Peritoneal Cancer Michael Morse, MD 8
Testing effectiveness (Phase 2)UnknownNCT01180504What this trial is testingConsolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian CancerWho this might be right forOvarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma University Hospital Heidelberg 36
Early research (Phase 1)Study completedNCT00003385What this trial is testingCombination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 48
Early research (Phase 1)Study completedNCT00352300What this trial is testingCarboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerWho this might be right forFallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more Gynecologic Oncology Group 43
Early research (Phase 1)Ended earlyNCT00003380What this trial is testingLiposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05803018What this trial is testingBL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological MalignanciesWho this might be right forGynecological Malignant TumorSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00003334What this trial is testingCombination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractWho this might be right forEndometrial CancerFallopian Tube CancerOvarian Cancer+1 more NYU Langone Health
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Study completedNCT03480750What this trial is testingTrial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian CancerWho this might be right forOvarian Neoplasms Malignant (Excl Germ Cell)Peritoneal CarcinomaFallopian Tube Cancer National Cheng-Kung University Hospital 18
Early research (Phase 1)Study completedNCT00003967What this trial is testingTopotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 24
Not applicableStudy completedNCT02518256What this trial is testingLavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and SpecificityWho this might be right forOvarian Epithelial Cancer Medical University of Vienna 270
Testing effectiveness (Phase 2)Study completedNCT00181701What this trial is testingIntraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian OriginWho this might be right forOvarian Carcinoma Massachusetts General Hospital 46
Not applicableStudy completedNCT02281487What this trial is testingHysterectomy for Benign Gynaecological Conditions With or Without TubectomyWho this might be right forAbdominal Hysterectomy (& Wertheim) Gynaecologisch Oncologisch Centrum Zuid 105
Testing effectiveness (Phase 2)Ended earlyNCT00086632What this trial is testingStudy of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer TreatmentWho this might be right forOvarian Cancer Unither Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT03100006What this trial is testingPhase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal OriginWho this might be right forEpithelial Ovarian Cancer National Cancer Centre, Singapore 13
Testing effectiveness (Phase 2)UnknownNCT04620954What this trial is testingClinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal OriginWho this might be right forEpithelial Ovarian Cancer National Cancer Centre, Singapore 31